Navigation Links
NxStage(R) Achieves Milestone with 3,000 End-Stage Renal Disease Patients Receiving Daily Home Hemodialysis Therapy
Date:11/3/2008

Patient adoption of daily home therapy continues to grow; Positive data supports broader acceptance within ESRD community.

LAWRENCE, Mass., Nov. 3 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that 3,000 end-stage renal disease (ESRD) patients are now prescribed to receive therapy using its NxStage(R) System One(TM), the first truly portable home hemodialysis machine. This latest milestone represents 35% growth in patient adoption since the end of 2007. The NxStage System One is now available at hundreds of dialysis centers in markets throughout the United States.

"We are pleased by the continuing, annual increase in patient adoption of daily home hemodialysis (DHD) with the NxStage System One," said Jeff Burbank, President and Chief Executive Officer of NxStage Medical, Inc. "This validates our strategy to build sustained growth by working closely with patients and their care-providers in key markets while continuing to broaden nationwide access. It is exciting to see how DHD with the NxStage System One is benefiting the lives of patients. The latest significant evidence of this impact are the just-released interim results of our landmark FREEDOM study, which show that NxStage's DHD therapy significantly improves patients' health-related quality-of-life in terms of recovery time, depressive symptoms and overall health-related quality-of-life, in comparison with conventional, thrice-weekly in-center hemodialysis treatment."

The NxStage System One is the first truly portable hemodialysis system cleared for home use by the FDA. Unlike traditional dialysis equipment, the System One plugs into a standard electrical outlet, requires n
'/>"/>

SOURCE NxStage Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Emil Paganini, MD, Joins NxStage(R) as Critical Care Medical Advisor
2. NxStage(R) Medical to Report Fourth Quarter & Full Year 2007 Financial Results on Tuesday, February 12th
3. Topical treatment for cold sores achieves efficacy of oral drugs; represents paradigm shift
4. ECRFPlus Achieves Milestone Multimillion Dollar Enterprise Agreement With CRO and Launches e-CRF+(TM): a CTMS and EDC Web Platform With ECG Analysis and Cardiac Safety Module.
5. Rochester Medical Implants Achieves ISO 13485:2003 Certification for Medical Device Manufacturing
6. Experimental Apartment in Beijing Achieves 99% Purity of Indoor Air
7. MD On-Line Achieves CAQH CORE(TM) Certification for Consistent Healthcare Administrative Data Exchange
8. iCAD Achieves Record-High Ratings in Mammography CAD User Satisfaction
9. Echocardiography Lab at Presbyterian Hospital of Dallas Achieves Prestigious Reaccreditation
10. Haemacure Achieves Major Milestone - Starts Processing Plasma in Its New Fractionation Facility
11. Companion Data Services Achieves ISO Certification for Quality Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2014)... episodes of low back pain are not linked to ... direction and precipitation. Findings published in Arthritis Care ... of Rheumatology (ACR), indicate that the risk of low ... wind gusts, but was not clinically significant. , ... experiences low back pain at some point in their ...
(Date:7/9/2014)... active in almost all types of cancer sends the ... help fuel a tumour,s uncontrolled growth, new research suggests. ... identified a molecular trigger responsible for ratcheting up activity ... that makes the building blocks cancer cells need to ... pathway, called SREBP, controls the flow of messages to ...
(Date:7/9/2014)... fecal transplantation is effective and safe for treating ... result of a study led by Colleen Kelly, M.D., ... at The Women,s Medicine Collaborative. The study and its ... in the American Journal of Gastroenterology . , ... has increased to epidemic proportions over the past decade. ...
(Date:7/9/2014)... 2014 There has been a sharp increase in ... Center using MyChart, the online, interactive service that allows ... their healthcare providers, schedule appointments, and renew prescriptions. , ... using MyChart each year increased five-fold, while ... than 10-fold, according to a study by Dr. ...
(Date:7/9/2014)... Infectious Diseases (NIAID), part of the National Institutes ... of CRS3123, an investigational oral antibiotic intended to ... ) infection. CRS3123 (previously known as REP3123) is ... while sparing normal intestinal bacteria. , The Phase ... men and women ages 18 to 45 in ...
Breaking Medicine News(10 mins):Health News:Low back pain? Don't blame the weather 2Health News:Signal may send cancer's cellular factories into overdrive 2Health News:Women's Medicine Collaborative examines safety of fecal transplant to treat C. difficile 2Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 2Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 3Health News:NIH launches Phase I clinical trial of novel drug to treat Clostridium difficile infection 2
... the Public Health Grid (PHGrid) technology during the 2009 ... and disease-control agencies when the next emergent disease appears, ... Journal of Grid and Utility Computing . Terry ... Control and Prevention, in Atlanta, Georgia, working with informatics ...
... is an EU-funded research project that develops objective ... Alzheimer,s disease. Diagnosis requires a holistic view of ... as, clinical tests, imaging and blood samples. ... to develop an objective indicator to diagnose Alzheimer,s ...
... June 14 (HealthDay News) -- A mist inhaler with the ... of death among people with chronic obstructive pulmonary disease (COPD), ... soluble form of Spiriva (tiotropium) is approved in 55 countries, ... the powdered form of Spiriva is commonly used to treat ...
... (HealthDay News) -- Patients with early-stage chronic kidney disease are ... a certain hormone, a new study says. Endocrine hormone ... known that levels of FGF-23 increase as kidney function declines ... increased risk of death in patients with kidney failure. But ...
... , Preschool children seem to grasp the true concept of ... value of groups of objects greater than three, research at ... that there are three objects doesn,t have to involve counting. ... necessary to determine how many objects there are," said Elizabeth ...
... PHILADELPHIA Scientists at Harvard University have created a ... observation of early stages of ovarian cancer metastasis. ... that are necessary for the force-dependent processes associated with ... cell biology at Harvard University. These findings are ...
Cached Medicine News:Health News:A grid approach to pandemic disease control 2Health News:Several methods for early diagnosis of Alzheimer's disease developed by European scientists 2Health News:Several methods for early diagnosis of Alzheimer's disease developed by European scientists 3Health News:Several methods for early diagnosis of Alzheimer's disease developed by European scientists 4Health News:COPD Drug Via Mist Inhaler Could Raise Death Risk: Study 2Health News:Hormone Linked to Death Risk in Those With Early Kidney Disease 2Health News:Learning to count not as easy as 1, 2, 3 2
(Date:1/15/2014)... 15, 2014 As health officials across the Midwest warn ... pharmacies in Michigan will offer free ... enabling Meijer pharmacists to administer tests and, in some cases, ... physician participating in the study. The ...
(Date:1/15/2014)... plc (LSE: SHP, NASDAQ: SHPG ) announces that it ... the announced tender offer for all of the outstanding shares of ... the waiver, the transaction is no longer conditional on OFT approval, ... 2014 following the currently scheduled expiration time, subject to the satisfaction ...
(Date:1/15/2014)... Medical is very pleased to announce the appointment of Mr. ... Officer.  Mark was promoted from his current role of Chief ... facilities in Massachusetts , Mississippi ... in 2012 with 20+ years of broad-based operations, sales, engineering ...
Breaking Medicine Technology:Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3
... Reportlinker.com announces that a new ... its catalogue: Retinal ... Assessment and Market Forecasts to 2017 ... Retinal Vein Occlusion (RVO) ...
... Pharmaceutical Group (NYSE: SCR ) ("Simcere" or ... development, manufacturing, and marketing of branded and proprietary pharmaceuticals ... of shareholders (the "Meeting") will be held on Thursday, ... meeting will be held in No.699-18, Xuanwu Avenue, Xuanwu ...
Cached Medicine Technology:Reportlinker Adds Retinal Vein Occlusion (RVO) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 2Reportlinker Adds Retinal Vein Occlusion (RVO) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 3Reportlinker Adds Retinal Vein Occlusion (RVO) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 4Reportlinker Adds Retinal Vein Occlusion (RVO) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 5Reportlinker Adds Retinal Vein Occlusion (RVO) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 6Reportlinker Adds Retinal Vein Occlusion (RVO) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 7Reportlinker Adds Retinal Vein Occlusion (RVO) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 8Reportlinker Adds Retinal Vein Occlusion (RVO) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 9Reportlinker Adds Retinal Vein Occlusion (RVO) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 10Simcere Pharmaceutical Group Provides Notice of Annual General Meeting 2
125I radioimmunoassay, Simple extraction procedure, Ready-to-use calibrators, Less than 0.1% crossreactivity with DHEA-SO4, 2-hour single incubation, 37C, Calibration Range: 0.5 30 ng/mL...
Inquire...
EL-RF/3 is for measurement of IgM, IgG, IgA RF with high specificity for rheumatoid arthritis....
Rapid latex slide agglutination assay for the qualitative and semi-quantitative determination of Rheumatoid Factors in human serum....
Medicine Products: